The New York Comprehensive Thalassemia Center has a rich history of research, both basic and clinical. Patients participate in single-center and multi-center trials of novel therapeutic agents, supported by the Clinical & Translational Science Center (CTSC) and overseen by the Institutional Review Board of Weill Cornell Medicine.
Open Clinical Trials
View and participate in ongoing clinical trials at the New York Comprehensive Thalassemia Center.